Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
107.75    -1.30 (-1.19%)
Bid:
107.80
Ask:
107.85
Spread: 0.05 (0.046%)
Market Cap: £62.71b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Board Change

15 Feb 2024 07:00

RNS Number : 1737D
Lloyds Banking Group PLC
15 February 2024
 

15 February 2024

LLOYDS BANKING GROUP: BOARD CHANGE

Lloyds Banking Group plc ("Group") announces that Lord Lupton has informed the Board that he intends to step down as a non-executive director of the Group at its 2024 annual general meeting having served almost seven years on the Board. Also, he will step down as Chair of Lloyds Bank Corporate Markets plc ("LBCM") at the same time. The process for the appointment of the next Chair of LBCM is well-advanced and John Owen, the Senior Independent Director of LBCM, will take on the role of interim Chair of LBCM when Lord Lupton steps down.

Sir Robin Budenberg, Group Chair, said "I would like to thank James for the valuable contribution he has made to the Board since June 2017 and for his leadership as the inaugural Chair of Lloyds Bank Corporate Markets and for his personal support for me since I became Chair. I wish James the best for the future. I would also like to thank John for taking on this important additional role."

- END -

For further information:

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

 

+44 (0) 7788 352 487

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQKQBPPBKDOBD
Date   Source Headline
28th Mar 20234:45 pmRNSTotal Voting Rights
27th Mar 20235:18 pmRNSTransaction in Own Shares
24th Mar 20235:38 pmRNSTransaction in Own Shares
24th Mar 20239:12 amRNSNotice of Redemption
23rd Mar 20235:33 pmRNSTransaction in Own Shares
23rd Mar 20232:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:27 pmRNSTransaction in Own Shares
22nd Mar 202311:25 amRNS2022 Annual Report and Accounts
21st Mar 20235:55 pmRNSNotice of AGM
21st Mar 20235:40 pmRNSTransaction in Own Shares
20th Mar 20235:26 pmRNSTransaction in Own Shares
17th Mar 20235:28 pmRNSTransaction in Own Shares
16th Mar 20235:47 pmRNSTransaction in Own Shares
15th Mar 20235:33 pmRNSTransaction in Own Shares
14th Mar 20235:20 pmRNSTransaction in Own Shares
13th Mar 20235:29 pmRNSTransaction in Own Shares
10th Mar 20235:58 pmRNSTransaction in Own Shares
10th Mar 20234:07 pmRNSDirector/PDMR Shareholding
9th Mar 20235:43 pmRNSTransaction in Own Shares
8th Mar 20236:06 pmRNSTransaction in Own Shares
8th Mar 20232:26 pmRNSDirector/PDMR Shareholding
7th Mar 20235:39 pmRNSTransaction in Own Shares
7th Mar 20233:08 pmRNS2022 Form 20F Filed
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
6th Mar 20235:52 pmRNSTransaction in Own Shares
3rd Mar 20235:41 pmRNSTransaction in Own Shares
2nd Mar 20235:37 pmRNSTransaction in Own Shares
2nd Mar 202312:04 pmRNSPublication of Final Terms
1st Mar 20235:26 pmRNSTransaction in Own Shares
28th Feb 20235:41 pmRNSTransaction in Own Shares
28th Feb 20233:37 pmRNSTotal Voting Rights
27th Feb 20235:26 pmRNSTransaction in Own Shares
27th Feb 20232:00 pmRNSDirector/PDMR Shareholding
24th Feb 20235:46 pmRNSTransaction in Own Shares
24th Feb 20235:03 pmRNS2022 Form 20F Filed
23rd Feb 20236:07 pmRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSShare Buyback Programme Commences
22nd Feb 202311:38 amRNSPublication of Suppl.Prospcts
22nd Feb 20237:00 amRNS2022 Annual Report and Accounts
22nd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20235:00 pmRNSDirector/PDMR Shareholding
31st Jan 20234:57 pmRNSTotal Voting Rights
11th Jan 20232:36 pmRNSPublication of Final Terms
11th Jan 20232:15 pmRNSDirector/PDMR Shareholding
3rd Jan 202310:00 amRNSBlock listing Interim Review
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20224:36 pmRNSDirector/PDMR Shareholding
12th Dec 20224:09 pmRNSDirector/PDMR Shareholding
7th Dec 20222:00 pmRNSBlock Listing of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.